We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

02 Jun 2026 - 04 Jun 2026
17 Jun 2026 - 19 Jun 2026

Bayer to Sell Diagnostics Division to Siemens for $5.3 Billion

By HospiMedica staff writers
Posted on 07 Jul 2006
Following on the heels of its successful takeover of drug company Schering AG (Berlin, Germany), the Bayer Group (Leverkusen, Germany) has taken a move that will enable still more concentration on pharmaceuticals by announcing plans to sell its diagnostics division to Siemens AG (Munich, Germany) for about U.S.$5.3 billion.

"We are concentrating on pharmaceuticals for both humans and animals, and products that can be promoted directly to patients,” explained Werner Wenning, chairman of the management board at Bayer AG.

The Diabetes Care Division will not be included in the sale nor will the diagnostic imaging business of Schering AG. More...
However, the systems business of the Diagnostics Division, with its emphasis on hardware, information technology (IT) networking, and laboratory equipment, is subject to different success factors, according to Bayer, and therefore will be included in the sale.

"Bayer Healthcare Diagnostics has grown considerably faster than the market in terms of earnings and profitability over the past three years,” said Arthur Higgins, chairman of the board of management of Bayer HealthCare AG. "So now is the right time to divest this successful business and thereby add value for the Bayer Group. Siemens is the ideal company to continue developing Bayer HealthCare Diagnostics as a core business.”

"With this acquisition we are continuing to consistently pursue our strategy of building the industry's first integrated diagnostics company that combines diagnostic imaging, laboratory diagnostics, and clinical information technology under one roof right along the value chain,” observed Erich Reinhardt, CEO and president of Siemens Medical Solutions.

The transaction will also help Bayer to reduce some of the debt incurred for the financing and acquisition of Schering.



Related Links:
Siemens AG
Bayer AG

Gold Member
Neonatal Heel Incision Device
Tenderfoot
Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Hypodermic Syringe
SurTract™ Safety Syringe
Glucose Meter
StatStrip®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: Reusable catheter patients used 35 percent fewer antibiotics compared to their single-use only counterparts. (Photo courtesy of the University of Southampton)

Reusable Intermittent Catheters Reduce Antibiotic Use Without Increasing Urinary Tract Infections

Intermittent self-catheterization, used to empty the bladder several times a day, can leave patients vulnerable to recurrent urinary tract infections and repeated antibiotic use. Reliance on single-use... Read more

Surgical Techniques

view channel
Image: Avvio Medical\'s technology combines microbubble-enhanced acoustic cavitation with smart catheter navigation to precisely target and break down ureteral stones, all without the need for routine stenting or general anesthesia (Photo courtesy of Avvio Medical)

Anesthesia-Sparing System Targets Faster Ureteral Stone Treatment

Ureteral stone care is often delayed by operating room scheduling constraints and growing wait times, leaving a gap between diagnosis and treatment. With no fundamentally new therapeutic approach introduced... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.